Insider Stock Trading History of Barnhill Gregory Hurd


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Barnhill Gregory Hurd since year 2005. The trader's CIK number is 1273979. At the time of this reporting, Barnhill Gregory Hurd is the Director of Pure Bioscience . (stock ticker symbol PURE). See this page for all insider trading activities at Pure Bioscience .

Note that in the past BARNHILL GREGORY HURD also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Barnhill Gregory Hurd since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2011-06-29 PURE Pure Bioscience Buy 50,000 .78 38,750
2011-06-21 PURE Pure Bioscience Buy 25,000 .89 22,350
2011-06-03 OSIR Osiris Therapeutics, Inc. Buy 25,000 7.20 179,975
2011-06-06 OSIR Osiris Therapeutics, Inc. Buy 25,000 7.07 176,700
2011-03-09 PURE Pure Bioscience Option Ex 50,000 1.65 82,500
2011-01-03 PURE Pure Bioscience Option Ex 50,000 .53 26,500
2010-07-07 PURE Pure Bioscience Buy 5,000 1.84 9,200
2010-04-14 PURE Pure Bioscience Buy 5,000 2.72 13,600
2010-04-06 PURE Pure Bioscience Buy 10,000 2.02 20,160
2010-03-15 PURE Pure Bioscience Buy 10,000 1.80 18,000
2010-01-27 PURE Pure Bioscience Sale 28,492 1.35 38,521
2010-01-26 PURE Pure Bioscience Sale 40,000 1.36 54,560
2010-01-19 PURE Pure Bioscience Sale 3,500 1.50 5,250
2010-01-20 PURE Pure Bioscience Sale 29,410 1.44 42,409
2010-01-21 PURE Pure Bioscience Sale 27,090 1.55 41,881
2010-01-14 PURE Pure Bioscience Sale 1,110 1.57 1,742
2010-01-15 PURE Pure Bioscience Sale 700 1.55 1,082
2010-01-13 PURE Pure Bioscience Sale 11,700 1.61 18,825
2009-12-24 PURE Pure Bioscience Sale 1,000 1.39 1,390
2009-12-22 PURE Pure Bioscience Sale 21,924 1.43 31,395
2009-12-23 PURE Pure Bioscience Sale 1,500 1.43 2,145
2009-12-21 PURE Pure Bioscience Sale 35,243 1.45 51,137
2009-12-14 PURE Pure Bioscience Option Ex 150,000 .53 79,500
2009-07-21 PURE Pure Bioscience Buy 10,000 1.67 16,700
2009-04-23 PURE Pure Bioscience Buy 5,000 1.69 8,450
2009-04-07 PURE Pure Bioscience Buy 5,000 1.75 8,745
2009-03-20 PURE Pure Bioscience Buy 5,000 1.75 8,750
2009-01-27 PURE Pure Bioscience Option Ex 150,000 .53 79,500
2008-12-29 PURE Pure Bioscience Buy 10,000 3.02 30,200
2008-10-24 PURE Pure Bioscience Buy 3,300 2.70 8,910
2008-10-23 PURE Pure Bioscience Buy 10,000 2.95 29,500
2008-10-22 PURE Pure Bioscience Buy 10,000 2.95 29,500
2008-10-17 PURE Pure Bioscience Buy 10,000 3.00 30,019
2008-10-17 PURE Pure Bioscience Buy 10,000 3.00 30,019
2008-07-02 PURE Pure Bioscience Buy 9,830 3.87 38,042
2008-06-26 PURE Pure Bioscience Buy 10,000 4.18 41,800
2008-04-21 PURE Pure Bioscience Buy 10,000 4.70 47,000
2008-04-07 PURE Pure Bioscience Buy 10,000 5.72 57,170
2008-04-07 PURE Pure Bioscience Buy 10,000 5.72 57,170
2008-04-07 PURE Pure Bioscience Buy 10,000 5.72 57,170
2007-02-05 OSIR Osiris Therapeutics, Inc. Option Ex 2,500 23.62 59,050

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Barnhill Gregory Hurd (Director of Pure Bioscience at the time of this reporting) see the Securities and Exchange Commission (SEC) website.